Aldumastat clinical trials
Also written GLPG1972.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How each study uses aldumastat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- GLPG1972
- 2
Studies by the year they started
7 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Protease Inhibitors source
Studies
Open first, then newest update. How each study uses aldumastat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee OsteoarthritisCompletedPhase 2Galapagos NVNCT03595618Written as GLPG1972How we know
- A Study in Healthy Volunteers to Compare Different Tablet Formulations of the Test Medicine, GLPG1972, Against the Current Tablet Formulation, and to Assess the Effect Food Has on One of the Test MedicinesCompletedPhase 1Galapagos NVNCT04137341Written as GLPG1972 - AHow we know
- A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given by Mouth and Into the Vein as an InjectionCompletedPhase 1Galapagos NVNCT04136327Written as GLPG1972 film-coated tabletsHow we know
- A Study With GLPG1972 in Osteoarthritis SubjectsCompletedPhase 1Galapagos NVNCT03311009Written as GLPG1972 cohort 1How we know
- Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral SolutionCompletedPhase 1Galapagos NVNCT03143725Written as GLPG1972How we know
- Bioavailability Study With GLPG1972CompletedPhase 1Galapagos NVNCT02851485Written as GLPG1972 600 mg oral solution fastedHow we know
- First-in-Human Single and Multiple Dose of GLPG1972CompletedPhase 1Galapagos NVNCT02612246Written as GLPG1972 single ascending dosesHow we know
Codes
What other systems call aldumastat · ClinicalTrials.gg INT016464
- UNII (FDA) EI4HZ6P03EALDUMASTATOne source FDA
- NCI Thesaurus C175739AldumastatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | EI4HZ6P03E | ALDUMASTAT | One source FDA |
| NCI Thesaurus | C175739 | Aldumastat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.